Title: Suicidal Behavior, Alcohol, and Alcohol Use Disorders <Slide 1>

Timothy W. Lineberry, M.D.

Alcohol Medical Scholars Program 3-14-08

 

I.    Introduction

      A.  Suicidal behavior is prevalent <Slide2 >

            1.   U.S. population 2006 =300 Million → suicidal thoughts (SI): 3.3%/yr 1

            2.   Annual prevalence suicide attempts: 0.6%

            3.   Lifetime prevalence of attempts: 4.6%

            4.   > 32,000 die by suicide/yr ↔ 1.4% of all U.S. deaths2 ↔ 0.01%/yr

      B.   Alcohol (alc) misuse is common <Slide 3>

            1.   U.S. adult population: ~ 90% lifetime alc use / 53% use alc past yr3

            2.   “Hazardous drinkers”→ (>5 drinks/day) : ~ 25% past yr 4, 5

            3.   Alc abuse prevalence (DSM-IV defined)6

                  a.   18% lifetime: men > women (~2:1)

                  b.   5% 12-month prevalence

            4.   Alc dependence prevalence (DSM-IV defined)6

                  a.   13% lifetime: men > women (~2:1)

                  b.   4% 12-month prevalence  

      C.  Alc use and suicidal behaviors often co-occur (more details later)

            1.   Acute use:  alc in ~ 40% attempts/completed suicide7

            2.   Alc abuse/dependence diagnosis (dx): present in ~25% all suicides8

      D.  This lecture answers 4 questions <Slide 4>

            1.   Definitions of alc misuse, major depression (MDD), & suicide-related behaviors

            2.   Relationships between alc dependence, MDD, and suicide-related behavior

            3.   How to screen and identify “at risk” patients

            4.   How to initially assess and manage “at risk” patients

II.   Definitions of alc misuse, MDD, and suicide-related behaviors        

      A.  Definitions regarding alcohol

            1.   At-risk/hazardous drinking <Slide 5>

                  a.   Potential alc use problems -- not abuse or dependence dx

                        i.    Men ≥ 5 drinks/day or ≥ 15 drinks/wk

                        ii.    Women ≥ 4 drinks/day and ≥ 8 drinks/wk

                        iii.   Risk for alcohol-related problems ↑ at those limits

            2.   Abuse - Repeated alc problems over 12 months with ≥ 1 of: <Slide 6>

                  a.   Inability to fulfill role obligations

                  b.   Use in physically hazardous situations 

                  c.   Legal problems

                  d.   Social or interpersonal problems

                  e.   Not dependence

            3.   Dependence - Repeated problems over 12 months with ≥ 3 of:  <Slide 7>

                  a.   Tolerance: ↑ use for same effect; ↓ effect with same amount used

                  b.   Withdrawal syndrome:  Use alc to ↓ symptoms

                  c.   Use larger/longer than intended

                  d.   Desire or unsuccessful efforts to cut down

                  e.   ↑ time spent in alcohol-related activities

                  f.    Give up important activities

                  g.   Continued use despite persistent problems

      B.   Definitions regarding MDD

            1.   MDD lifetime prevalence:  ♀ 15%: ♂ 8% <Slide 8>

                  a.   > 5  following symptoms nearly every day during 2-week period (see below)

                  b.   Represents change from previous functioning

                  c.   May be subjective report or observation of others

                  d.   Must have at least depressed mood and/or ↓ interest or pleasure (i. or ii.)

                        i.    Depressed mood most of the day

                        ii.    Markedly diminished interest or pleasure in all or almost all activities

                        iii.   Weight loss or weight gain or ↓ or ↑ in appetite <Slide 9>

                        iv. ↓ Or ↑ in sleep

                        v.   Psychomotor agitation or retardation

                        vi.   Fatigue or ↓ energy

                        vii.  Feelings of worthlessness or excessive/inappropriate guilt

                        viii.↓ Ability to think/concentrate or indecisiveness

                        ix.   Recurrent thoughts of death or recurrent SI +/- specific plan or attempt

      C.  Definitions regarding suicide-related behavior <Slide 10>

            1.   Suicidal ideation (SI) = thoughts of suicide

            2.   Suicide attempt = deliberate self-harm with intent to die

                  3.   Completed suicide = deliberate self-harm resulting in death

III. What are relationships of alc, MDD, and suicide related behavior? <Slide 11>

      A.. Prevalence of suicide-related behaviors with alc use disorders <Slide 12>

            1.   Alcohol use disorders: ~25% all suicides (psych autopsy)8

            2.   Suicidal ideation (SI) in alc dependence: ↑ 3-5 X vs. Gen. Pop. 9 <Slide 13>

            3.   Suicide attempts in alc dependence: ↑ 4-6 X vs. Gen. Pop.

            4.   Completed suicide in alc dependence: 7%10  

      B.   Prevalence of suicide-related behaviors with MDD <Slide 14>

            1.   Suicide & depression: ~40 of all suicides (psychological autopsy)8

            2.   Suicide attempts in major depression: 20% with lifetime attempt <Slide 15>

            3.   Suicide in depression → varies with severity of illness 11                                                                   a.      Psychiatric inpatient + SI:  9% suicide/lifetime

                  b.   Inpt without SI:  4% suicide/lifetime

                  c.   Outpatient depression:  2% suicide/lifetime       

      C.  Alc dependence + depression12-14 <Slide 16>

            1.   Depressive symptoms are common in heavy drinking

                  a.   80% patients with alc dependence report depressive sxs lifetime

                  b.   Sustained heavy alcohol use can induce depressive symptoms

            2.   Syndromes seen in context of heavy drinking<Slide 17>

                  a.   “Independent” MDD

                        i.    Predates alc dependence dx or occurring in times of sustained abstinence

                        ii.    More likely to have family history of MDD than alcohol-induced

                        iii.   15% of alc dependence patients

                  b.   Alcohol-induced MDD <Slide 18>

                        i.    Temporary sxs associated with alcohol use

                        ii.    Typically resolve in ~ 4 weeks

                        iii.   Do not occur during periods of sustained abstinence

                        iv.   Less likely to have family history of MDD

                        v.   26% of alc dependence patients  <Slide 19>

            3.   Depression + alc dependence =  ­ suicide rate <Slide 20>

                  a.   Independent depression ↑ suicide attempt rate vs. alc induced 15

                  b.   Suicide risk effects amplified by increasing age

                  c.   Depression and/or alc dependence make up ~65% of all suicides8

            4.  Alcohol use disorders, suicide and depression are interrelated <Slide 21>

IV. How to screen and identify patients “at risk” (alc problems + suicide) <Slide 22>

      A.  First principle – ASK everyone systematically <Slide 23>

            1.   Physician ability to ID alcohol, MDD, & suicide related problems is poor

                  a.   <25% patients routinely screened for alcohol use16

                  b.   ~40% patients with depression missed by primary care17

                  c.   ~ 35% of patients with depression asked about suicide18

                  d.   MDs report discomfort with asking, miss obvious clinical patterns

            2.   Patients expect to be <Slide 24>

                  a.   Asked about alcohol use/emotional problems

                  b.   Provided guidance about use and risky behaviors

                  c.   Judge MD on attention to above

      B.   Ask all patients about alc problems using evidence-based screening tools <Slide 25>

            1.  Screening ≠ diagnosis → positive screen requires full evaluation

            2.   CAGE <Slide 26>

                  a.   Four questions: cut down, annoyed, guilt, eye-opener19 (see attached)

                  b.   > Two affirmative answers = positive test

                  c.   Sensitivity → 50-80%; specificity → ~ 80%

                  d.  Doesn’t screen for hazardous drinking 

            3.   Alcohol Use Disorders Identification Test (AUDIT) <Slide 27>

                  a.   Ten-item questionnaire developed by W.H.O.20(see attached)

                  c.   Score of > 8 = positive test for hazardous drinking/ ↑alc. dx

                  d.   Sensitivity → 50-90%;  specificity → 80%

            4.   AUDIT-C

                  a.   3-question survey using the consumption ?s from AUDIT20 (see attached)

                  b.   Equal in sensitivity/specificity to full AUDIT

                  c.  Positive score for identifying hazardous drinking → Men > 4; Women > 3

      B.   Physical examination <Slide 28>

            1.   Hypertension: ł 3 drinks/day with ­ blood pressure 

            2.   Hepatosplenomegaly:  ­ in liver or spleen size

            3.   Peripheral neuropathy:  15% of those with alc dependence

      C.        State markers of heavy alc use can help21 <Slide 29>

            1.   Definition: blood tests which temporarily ∆ if drink 5+ drinks/d X 5+days

            2.   Gamma-glutamyl transferase (GGT) >35 µ/L

                  a.   Involved in amino acid transport

                  b.   Sensitivity:  ~ 70% men/50% women; specificity ~70% both sexes

            3.   Carbohydrate-deficient transferrin (CDT) > 2.5%22

                  a.   Heavy drinking association over extended periods

                  b.   Change in proportion of transferrin

                  c.   Sensitivity:  30-75%:  M > W; specificity:  up to 90%

                  d.   Interpretation complicated by iron deficiency

            4.   CBC w/mean corpuscular volume

                  a.   ­ alcohol use affects RBC production

                  b.   MCV ­ = > 92

                  c.   unknown sensitivity and specificity

            5.   Aspartate transaminase (AST)

                  a.   Liver function test → Multiple reasons for ↑ beyond alc

                  b.   Sensitivity with heavy drinking 25-45%; specificity as high as 90%

                  c.   Combined with alanine transaminase (ALT) testing for ratio

                  d.   AST/ALT ratio > 2: ↑ probability alc hepatitis23 (*invalid → values > 400)

      D.  Ask patients with positive alc problem screening about depression<Slide 30>

            1.   Two question depression screening (in the past month)24

                  a.   How often have you been bothered by feeling down, depressed, or hopeless?

                  b.   How often have you been bothered by little interest/pleasure in doing things?

                  c.   > 1 affirmative answer = positive test

            2.   Sensitivity: 96%; specificity: 57%

            3.   Screening ≠ diagnosis → positive screen requires full evaluation                  

V.  How to manage alc patients identified “at risk” (at risk = screen positive for alc) <Slide 31>

      A. Identify heavy drinking/alc dependence using diagnostic criteria <Slide32 >

      B.   Interview and define presence of MDD in pts with alc dependence <Slide 33>

            1.   Timeline interview for presence of depressive symptoms

                  a.   Carefully assess presence of MDD sxs during lifetime

                  b.   Are sxs present or absent during sustained abstinence?

                  c.   Family history of depression? (↑likelihood of independent)

            2.   Important to distinguish alcohol-induced from independent for rx reasons

                  a.   Alc-induced depressions markedly improve with 2-4 weeks abstinence                                     b.      Independent MDD require six to nine months of antidepressant rx               

      C. Evidence-based treatment of underlying alc disorders <Slide 34>

            1.   Motivational interviewing 25

                  a.   Emphasize change

                  b.   Discuss patients resistance to change

                  c.   Focus on patient's perspective

                  d.   Encourage change acceptable to patient

            2.   Cognitive behavioral therapy (CBT) for alc dependence

                  a.   Help patient change view of role in drinking

                  b.   Help change behaviors to ↑ sobriety

                        i.    Recognize and avoid risky situations

                        ii.    Get sober social network                                       

            3.   Medications for alc dependence (all used with psychosocial support treatments)

                  a.   Disulfiram (Antabuse): sensitizing agent to alcohol

                        i.    Inhibits alcohol dehydrogenase → ↑ blood acetaldehyde levels

                        ii.    ↑ Acetaldehyde levels → reaction: nausea/vomiting/blood pressure ∆s

                        iii.   Requires monitoring of administration, questionable efficacy

                        iv.   Medication interactions

                        v.  Dosing: 250 mg/day

                  b.   Naltrexone (Revia): opioid antagonist

                        i.    Decrease craving for/pleasurable response to alc use

                        ii.    Nausea, hepatotoxicity

                        iii.   Conflicting efficacy data

                        iv.   Dosing: 50 – 100 mg/day

                  c.   Acamprosate (Campral): glutamate receptor modulator

                        i.    Derivative of taurine (amino acid), primarily renally excreted

                        ii.    Alleviates physiological/psychological distress of abstinence

                        iii.   Dosing: ~ 2 gms/day (666 mg tid)

      D.  Perform suicide risk assessment (SAFE-T attached) <Slide 35>

            1.   Assess risk factors which ↑ likelihood of suicide-related behaviors

                  a.   Access to firearms or other lethal means

                  b.   Other psychiatric diagnoses (e.g. Panic Disorder, Personality Disorders)

                  c.   Symptoms which increase risk: agitation/anxiety, hallucinations, ↓ sleep

                  d.   Family history of suicide?

                  e.  Past history of suicide attempt(s)? Number, sought help, lethality

            2.  Assess protective factors which ↓ risk of suicide-related behaviors

                  a.   Internal: positive coping with stress, religious beliefs, frustration tolerance

                  b.   External: responsibility to family, social supports, + therapeutic relationships

            3.   Inquire about suicide using stepwise progression <Slide 36>

                  a.   Have you had feelings of hopelessness?  Can’t go on?  No future?

                  b.   Thoughts of death?  Feeling better off dead?

                  c.   Thoughts of suicide?  How often?  How intense? How long have they lasted?

                  d.   Planning for suicide:  Specific plan?  Obtaining means?  Rehearsal?

                  e.   Suicidal intent → active desire to hurt yourself now?

            4.   Define level of risk/care required based on clinical judgment <Slide 37>

                  a.   Low risk = no SI, no plan, no intent, no behavior → outpt f/u or consultation

                  b.   Moderate = SI +/- plan; no intent/behavior→ urgent referral to psychiatry/ ER

                  c.   High = thoughts/plan/intent/status post attempt/agitation → hospitalization

            5.   Document risk assessment rationale, level of care & treatment plan to ↓ risk

                  a.   Removal of firearms

                  b.   Contact with family

            6.   Initial assessment and management summary

                  a.   + screen → fuller assessment guided by disorder criteria

                  b.  Define MDD in pts with alc use disorder

                  c.  Rx underlying disorder w/evidence-based treatments

                  d.   Perform suicide risk assessment

VI. Summary <Slide 38>

      A.  Definitions: alc, dep, and suicide related-behaviors

      B.   Relationships of alc, dep, and suicide related behavior?

      C.  Screen and identify

      D.  Initially assess and manage

 


 

 

1.    Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. Jama 2005 May 25;293(20):2487-2495.

2.    CDC Fact Sheet: Suicide. 2007.

3.    Foster SE, Vaughan RD, Foster WH, Califano JA, Jr. Alcohol consumption and expenditures for underage drinking and adult excessive drinking. Jama 2003 Feb 26;289(8):989-995.

4.    Berger LK, Fendrich M, Lippert A. Prevalence and characteristics of hazardous drinkers: results of the Greater Milwaukee Survey. Wisconsin medical journal 2007 Oct;106(7):389-393.

5.    Hawkins EJ, Kivlahan DR, Williams EC, Wright SM, Craig T, Bradley KA. Examining quality issues in alcohol misuse screening. Subst Abus 2007;28(3):53-65.

6.    Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of general psychiatry 2007 Jul;64(7):830-842.

7.    Cherpitel CJ, Borges GL, Wilcox HC. Acute alcohol use and suicidal behavior: a review of the literature. Alcoholism, clinical and experimental research 2004 May;28(5 Suppl):18S-28S.

8.    Bertolote JM, Fleischmann A, De Leo D, Wasserman D. Psychiatric diagnoses and suicide: revisiting the evidence. Crisis 2004;25(4):147-155.

9.    Driessen M, Veltrup C, Weber J, John U, Wetterling T, Dilling H. Psychiatric co-morbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction (Abingdon, England) 1998 Jun;93(6):889-894.

10.   Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998 Jan;172:35-37.

11.   Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. The American journal of psychiatry 2000 Dec;157(12):1925-1932.

12.   Conner KR, Hesselbrock VM, Meldrum SC, et al. Transitions to, and correlates of, suicidal ideation, plans, and unplanned and planned suicide attempts among 3,729 men and women with alcohol dependence. Journal of studies on alcohol and drugs 2007 Sep;68(5):654-662.

13.   Conner KR, Hesselbrock VM, Schuckit MA, et al. Precontemplated and impulsive suicide attempts among individuals with alcohol dependence. Journal of studies on alcohol 2006 Jan;67(1):95-101.

14.   Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. The American journal of psychiatry 1997 Jul;154(7):948-957.

15.   Preuss UW, Schuckit MA, Smith TL, et al. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempts. Journal of studies on alcohol 2002 Jul;63(4):498-502.

16.   Babor TE, Higgins-Biddle J, Dauser D, Higgins P, Burleson JA. Alcohol screening and brief intervention in primary care settings: implementation models and predictors. Journal of studies on alcohol 2005 May;66(3):361-368.

17.   Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Archives of family medicine 1995 Feb;4(2):99-105.

18.   Feldman MD, Franks P, Duberstein PR, Vannoy S, Epstein R, Kravitz RL. Let's not talk about it: suicide inquiry in primary care. Annals of family medicine 2007 Sep-Oct;5(5):412-418.

19.   Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clinical and investigative medicine 2007;30(1):33-41.

20.   Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcoholism, clinical and experimental research 2007 Feb;31(2):185-199.

21.   Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction (Abingdon, England) 2003 Dec;98 Suppl 2:31-43.

22.   Dillie KS, Mundt M, French MT, Fleming MF. Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample. Alcoholism, clinical and experimental research 2005 Nov;29(11):2008-2014.

23.   Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. The American journal of gastroenterology 1999 Apr;94(4):1018-1022.

24.   Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997 Jul;12(7):439-445.

25.   Kaner EF, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane database of systematic reviews (Online) 2007(2):CD004148.